Acta Med. 2003, 46: 183-188

https://doi.org/10.14712/18059694.2019.31

Platelets Activation in Patients Undergoing PTCA and Their Responsiveness After in vitro Stimulation

Martina Loudová, Jan Krejsek

Charles University in Prague, Faculty of Medicine in Hradec Králové, Department of Clinical Immunology and Allergology, Hradec Králové, Czech Republic

Received May 1, 2003
Accepted August 1, 2003

Crossref Cited-by Linking

  • Zhou Xue, Liu Xing, Liu Hongmei, Dou Shuang, Chen Kangyin, Zhang Xiaowei, Wang Weiding, Wang Xuewen, Che Jingjin: CD36+/CD61+ Microparticles Correlate with the Risk of Percutaneous Cardiac Interventions in Coronary Artery Disease Patients and the Effects of Ticagrelor. Cardiovasc Drugs Ther 2022, 36, 455. <https://doi.org/10.1007/s10557-021-07184-0>
  • Kling Dorothee, Stucki Corinne, Kronenberg Sven, Tuerck Dietrich, Rhéaume Eric, Tardif Jean-Claude, Gaudreault Jacques, Schmitt Christophe: Pharmacological control of platelet-leukocyte interactions by the human anti-P-selectin antibody inclacumab – preclinical and clinical studies. Thrombosis Research 2013, 131, 401. <https://doi.org/10.1016/j.thromres.2013.02.020>
  • Mäyränpää Mikko I., Reséndiz Julio C., Heikkilä Hanna M., Lindstedt Ken A., Kovanen Petri T.: Improved Identification of Endothelial Erosion by Simultaneous Detection of Endothelial Cells (CD31/CD34) and Platelets (CD42b). Endothelium 2007, 14, 81. <https://doi.org/10.1080/10623320701346783>
Crossref Cited-by Linking logo